Xiangying Kong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xiangying Kong has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
Jingbo Wang
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Beijing, China
6 shared publications- Xiaohui Su
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China
6 shared publications Mingzhu Qi
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Beijing, China
5 shared publicationsXiaohui Su
Institute of Chinese Materia Medica China Academy of Chinese Medical Sciences Beijing China
5 shared publicationsFengyu Huang
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Beijing, China
4 shared publications- Na Lin
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China
4 shared publications
Latest Publications
- Open Access
- 31 October 2026
- Published by Wiley in Advanced Science
Cross‐Organ Multi‐Omics Profiling of Systemic Alterations in 5xFAD Mice and Changes Associated with Huanglian Jiedu Decoction Treatment
Alzheimer's disease (AD) is increasingly recognized as a systemic disorder involving metabolic abnormalities beyond the brain, but links between hepatic alterations and neuroinflammation remain unclear. We integrated behavioral, histopathological, transcriptomic, proteomic, phosphoproteomic, and metabolomic analyses in male mice assigned to WT ( n = 15), AD ( n = 16), high‐dose HLJDD ( n = 16), low‐dose HLJDD ( n = 11), and donepezil ( n = 10) groups and treated for 10 weeks. Longitudinal behavioral data were analyzed using repeated‐measures models, and omics p ‐values were adjusted using the Benjamini–Hochberg FDR procedure. Cognitive impairment, glial activation, and neuroinflammation were accompanied by hepatic metabolic disturbances and alterations in insulin signaling and energy metabolism, implicating PPAR and PI3K/Akt‐related processes. HLJDD, particularly at the high dose, improved behavioral and neuropathological outcomes and shifted abnormalities in TCA‐cycle metabolites, amino acid neurotransmitters, and oxidative balance toward WT levels. To assess hepatocyte contributions to microglial inflammation, we established an AML12–BV2 conditioned‐medium model with hepatocyte PPAR‐γ knockdown. Conditioned medium from LPS/HLJDD‐cotreated AML12 cells elicited lower inflammatory responses in BV2 cells than medium from LPS‐treated hepatocytes. PPAR‐γ knockdown attenuated this effect, supporting a hepatocyte PPAR‐γ‐dependent contribution to microglial regulation and further investigation of hepatic involvement in HLJDD‐associated neuroprotection.
- 31 October 2026
- Published by Wiley in Advanced Science
Open AccessCross‐Organ Multi‐Omics Profiling of Systemic Alterations in 5xFAD Mice and Changes Associated with Huanglian Jiedu Decoction Treatment
Alzheimer's disease (AD) is increasingly recognized as a systemic disorder involving metabolic abnormalities beyond the brain, but links between hepatic alterations and neuroinflammation remain unclear. We integrated behavioral, histopathological, transcriptomic, proteomic, phosphoproteomic, and metabolomic analyses in male mice assigned to WT ( n = 15), AD ( n = 16), high‐dose HLJDD ( n = 16), low‐dose HLJDD ( n = 11), and donepezil ( n = 10) groups and treated for 10 weeks. Longitudinal behavioral data were analyzed using repeated‐measures models, and omics p ‐values were adjusted using the Benjamini–Hochberg FDR procedure. Cognitive impairment, glial activation, and neuroinflammation were accompanied by hepatic metabolic disturbances and alterations in insulin signaling and energy metabolism, implicating PPAR and PI3K/Akt‐related processes. HLJDD, particularly at the high dose, improved behavioral and neuropathological outcomes and shifted abnormalities in TCA‐cycle metabolites, amino acid neurotransmitters, and oxidative balance toward WT levels. To assess hepatocyte contributions to microglial inflammation, we established an AML12–BV2 conditioned‐medium model with hepatocyte PPAR‐γ knockdown. Conditioned medium from LPS/HLJDD‐cotreated AML12 cells elicited lower inflammatory responses in BV2 cells than medium from LPS‐treated hepatocytes. PPAR‐γ knockdown attenuated this effect, supporting a hepatocyte PPAR‐γ‐dependent contribution to microglial regulation and further investigation of hepatic involvement in HLJDD‐associated neuroprotection.
- Open Access
- 29 April 2026
- Published by Wolters Kluwer Health in Science of Traditional Chinese Medicine
Astragali Radix–Chuanxiong Rhizoma mitigates ischemic stroke by inhibiting NET formation via the C5a/C5aR1 pathway
Background: Ischemic stroke (IS) is a leading cause of death and disability worldwide, posing a serious threat to human health. The herbal pair Astragali Radix–Chuanxiong Rhizoma (HQ–CX) is commonly used in the treatment of IS. However, the synergistic effects and underlying mechanisms of this herbal combination remain unclear. Objective: This study aimed to evaluate the therapeutic effects of the HQ–CX herbal pair on IS and to investigate its underlying mechanisms. Methods: A rat model of middle cerebral artery occlusion (MCAO) combined with Qi deficiency and blood stasis syndrome (QDBS) was established. The effects of HQ–CX on QDBS-MCAO rats, including improvements in QDBS symptoms, neurological function, and blood flow recovery in the ischemic area, were assessed by Qi deficiency syndrome score, blood stasis syndrome score, modified neurological severity score, cerebral blood flow measurement, and Nissl staining. Transcriptome analysis was conducted to predict the molecular mechanisms underlying the therapeutic effects of HQ–CX in IS. Additional experimental techniques, including enzyme-linked immunosorbent assay, immunofluorescence, Western blot analysis, and treatment with the pharmacological inhibitor deoxyribonuclease I, were employed to validate the efficacy of HQ–CX and explore its potential molecular targets. Furthermore, the intestinally absorbed chemical constituents of HQ–CX were identified by UPLC-Orbitrap-MS analysis, and its effects on neutrophil extracellular trap (NET) formation in vitro were evaluated through enzyme-linked immunosorbent assay, Western blot, and immunofluorescence assays. Results: In this study, HQ–CX not only alleviated symptoms associated with QDBS but also enhanced blood flow restoration in ischemic regions, thereby reducing infarct size in MCAO rats after ischemia. Transcriptomic analysis revealed that HQ–CX may exert neuroprotective effects by inhibiting NET formation, a potential therapeutic target for IS, through suppression of complement component 5a receptor 1, peptidyl arginine deiminase 4, and integrin subunit beta 3 expression. Furthermore, HQ–CX significantly reduced plasma levels of cell-free DNA and histone-DNA complexes in MCAO rats, and decreased the expression of myeloperoxidase and citrullinated histone H3 in the pia mater, cortex, and striatum of the ischemic hemisphere. Interestingly, HQ–CX failed to provide additional neuroprotection when NETs were degraded by deoxyribonuclease I, suggesting that its neuroprotective effects against ischemic injury are primarily mediated through inhibition of NET formation. Conclusion: HQ–CX exerts protective effects against IS by inhibiting NET formation through the complement component 5a/complement component 5a receptor 1 signaling pathway. These findings provide scientific evidence supporting the clinical efficacy of this herbal pair in the treatment of IS.
- 29 April 2026
- Published by Wolters Kluwer Health in Science of Traditional Chinese Medicine
Open AccessAstragali Radix–Chuanxiong Rhizoma mitigates ischemic stroke by inhibiting NET formation via the C5a/C5aR1 pathway
Background: Ischemic stroke (IS) is a leading cause of death and disability worldwide, posing a serious threat to human health. The herbal pair Astragali Radix–Chuanxiong Rhizoma (HQ–CX) is commonly used in the treatment of IS. However, the synergistic effects and underlying mechanisms of this herbal combination remain unclear. Objective: This study aimed to evaluate the therapeutic effects of the HQ–CX herbal pair on IS and to investigate its underlying mechanisms. Methods: A rat model of middle cerebral artery occlusion (MCAO) combined with Qi deficiency and blood stasis syndrome (QDBS) was established. The effects of HQ–CX on QDBS-MCAO rats, including improvements in QDBS symptoms, neurological function, and blood flow recovery in the ischemic area, were assessed by Qi deficiency syndrome score, blood stasis syndrome score, modified neurological severity score, cerebral blood flow measurement, and Nissl staining. Transcriptome analysis was conducted to predict the molecular mechanisms underlying the therapeutic effects of HQ–CX in IS. Additional experimental techniques, including enzyme-linked immunosorbent assay, immunofluorescence, Western blot analysis, and treatment with the pharmacological inhibitor deoxyribonuclease I, were employed to validate the efficacy of HQ–CX and explore its potential molecular targets. Furthermore, the intestinally absorbed chemical constituents of HQ–CX were identified by UPLC-Orbitrap-MS analysis, and its effects on neutrophil extracellular trap (NET) formation in vitro were evaluated through enzyme-linked immunosorbent assay, Western blot, and immunofluorescence assays. Results: In this study, HQ–CX not only alleviated symptoms associated with QDBS but also enhanced blood flow restoration in ischemic regions, thereby reducing infarct size in MCAO rats after ischemia. Transcriptomic analysis revealed that HQ–CX may exert neuroprotective effects by inhibiting NET formation, a potential therapeutic target for IS, through suppression of complement component 5a receptor 1, peptidyl arginine deiminase 4, and integrin subunit beta 3 expression. Furthermore, HQ–CX significantly reduced plasma levels of cell-free DNA and histone-DNA complexes in MCAO rats, and decreased the expression of myeloperoxidase and citrullinated histone H3 in the pia mater, cortex, and striatum of the ischemic hemisphere. Interestingly, HQ–CX failed to provide additional neuroprotection when NETs were degraded by deoxyribonuclease I, suggesting that its neuroprotective effects against ischemic injury are primarily mediated through inhibition of NET formation. Conclusion: HQ–CX exerts protective effects against IS by inhibiting NET formation through the complement component 5a/complement component 5a receptor 1 signaling pathway. These findings provide scientific evidence supporting the clinical efficacy of this herbal pair in the treatment of IS.
- Open Access
- 4 April 2026
- Published by Springer Nature in Cellular & Molecular Biology Letters
- Vol. 31 (1)
Integrated analysis of single-cell RNA sequencing, transcriptomics, and thermal proteome profiling identifies PLCG1 as the therapeutic target of isopimpinellin in treating rheumatoid arthritis
Isopimpinellin (ISOP), derived from Toddalia asiatica (L.) Lam, is thought to possess anti-inflammatory potential. However, the effects of ISOP on rheumato
- 4 April 2026
- Published by Springer Nature in Cellular & Molecular Biology Letters
- Vol. 31 (1)
Open AccessIntegrated analysis of single-cell RNA sequencing, transcriptomics, and thermal proteome profiling identifies PLCG1 as the therapeutic target of isopimpinellin in treating rheumatoid arthritis
Isopimpinellin (ISOP), derived from Toddalia asiatica (L.) Lam, is thought to possess anti-inflammatory potential. However, the effects of ISOP on rheumato
- 23 March 2026
- Published by Elsevier in Phytomedicine
- Vol. 155, 158101
Trifolirhizin alleviates bone destruction in rheumatoid arthritis by inhibiting osteoclast differentiation through the activation of FPR2
- 23 March 2026
- Published by Elsevier in Phytomedicine
- Vol. 155, 158101
Trifolirhizin alleviates bone destruction in rheumatoid arthritis by inhibiting osteoclast differentiation through the activation of FPR2
- 17 December 2025
- Published by Elsevier in Phytomedicine
- Vol. 150, 157713
Artesunate ameliorates leflunomide low-response against bone destruction in rheumatoid arthritis via cGMP-PKG signalling
- 17 December 2025
- Published by Elsevier in Phytomedicine
- Vol. 150, 157713
Artesunate ameliorates leflunomide low-response against bone destruction in rheumatoid arthritis via cGMP-PKG signalling
- Open Access
- 5 November 2025
- Published by Elsevier in Cell Reports Medicine
- Vol. 6 (11) , 102430
Mesothelin as a biomarker and potential therapeutic target in rheumatoid arthritis bone destruction
- 5 November 2025
- Published by Elsevier in Cell Reports Medicine
- Vol. 6 (11) , 102430
Open AccessMesothelin as a biomarker and potential therapeutic target in rheumatoid arthritis bone destruction
- Open Access
- 20 August 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (8) , 1200
TMCO1 as an Endoplasmic Reticulum Calcium Load-Activated Channel: Mechanisms and Disease Implications
Calcium ions (Ca2+) play a vital role in many biological processes. Transmembrane and coiled-coil domain 1 (TMCO1) has been characterized as an endoplasmic reticulum (ER) transmembrane protein in recent years. It keeps the cytoplasm and ER’s Ca2+ homeostasis stable by acting as a novel calcium channel. Studies from different laboratories have revealed that the mutation or deficiency of TMCO1 is closely correlated with several diseases, including cerebro-facio-thoracic dysplasia (CFTD), glaucoma, premature ovarian failure (POF), osteoporosis, and cancer. Here, we review the characteristics of TMCO1 and its involvement in related diseases, which may provide useful information for developing therapeutic strategies for these diseases, as well as promote further research on this protein.
- 20 August 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (8) , 1200
Open AccessTMCO1 as an Endoplasmic Reticulum Calcium Load-Activated Channel: Mechanisms and Disease Implications
Calcium ions (Ca2+) play a vital role in many biological processes. Transmembrane and coiled-coil domain 1 (TMCO1) has been characterized as an endoplasmic reticulum (ER) transmembrane protein in recent years. It keeps the cytoplasm and ER’s Ca2+ homeostasis stable by acting as a novel calcium channel. Studies from different laboratories have revealed that the mutation or deficiency of TMCO1 is closely correlated with several diseases, including cerebro-facio-thoracic dysplasia (CFTD), glaucoma, premature ovarian failure (POF), osteoporosis, and cancer. Here, we review the characteristics of TMCO1 and its involvement in related diseases, which may provide useful information for developing therapeutic strategies for these diseases, as well as promote further research on this protein.
- Open Access
- 31 March 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (4) , 510
Comparison of the Blood–Brain Barrier Penetration Ability and Anti-Neuroinflammatory Activity of Chromones in Two Types of Agarwood
Background/Objectives: Agarwood has a good neuroprotective effect and is often used to relieve anxiety and treat insomnia. This study compared the similarities and differences in the chromone components of two types of agarwood. It further investigated the absorption and brain distribution characteristics of these components in rats and their neuroprotective effects mediated through anti-neuroinflammatory pathways. Methods: This study confirmed, through ITS2 barcoding and chloroplast genome analysis, that both the ordinary and Qi-Nan agarwood are derived from Aquilaria sinensis. A comparative analysis of chromones in ethanol extracts derived from ordinary and Qi-Nan agarwood, as well as those capable of penetrating the blood-brain barrier in vivo, was conducted using UPLC-Q-TOF-MS. Subsequently, an in vitro neuroinflammatory model was established via lipopolysaccharide (LPS)-stimulated BV-2 cells to evaluate the anti-neuroinflammatory activity of differential chromones. Results: UPLC-Q-TOF-MS characterization revealed the chromone components in the two types of agarwood: A total of 81 chromone compounds were identified in the ethanol extracts of ordinary agarwood (OAE) (20 THPECs, 42 FTPECs, and 19 BI), while 41 were identified in the ethanol extracts of Qi-Nan agarwood (QNE) (11 THPECs and 30 FTPECs). Pharmacokinetic analysis in rats showed that 14 components from OAE (eight THPECs and six FTPECs) penetrated the rat serum, and 10 of these 14 components penetrated the blood–brain barrier (BBB). Twelve FTPECs from QNE penetrated the rat serum, all of which penetrated the BBB. The total peak area of the total ion current (TIC) was calculated for the samples, and the TIC of the serum was compared to that of the brain tissue from the same rat to roughly estimate the ratio. The results demonstrated that the capability of FTPECs to traverse the blood–brain barrier is substantially superior to that of THPECs. Correspondingly, only FTPECs were detected using DESI-MS imaging; no THPECs were detected in rat brain tissue, and DESI-MS imaging localized FTPECs to neuroanatomic regions (cerebral cortex, thalamus, and hippocampus). In vitro neuroinflammatory assays revealed the superior anti-inflammatory efficacy of QNE over OAE (IL-6/TNF-α suppression, p < 0.05), correlating with its FTPEC-rich composition. Conclusions: Structure–activity relationships identified FTPECs as potent inhibitors of pro-inflammatory cytokines, exhibiting enhanced BBB penetration (blood–brain relative abundance > 1). These findings establish FTPECs as prioritized candidates for CNS-targeted therapeutics, with QNE’s pharmacological superiority attributed to its FTPEC dominance and optimized BBB transit capacity.
- 31 March 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (4) , 510
Open AccessComparison of the Blood–Brain Barrier Penetration Ability and Anti-Neuroinflammatory Activity of Chromones in Two Types of Agarwood
Background/Objectives: Agarwood has a good neuroprotective effect and is often used to relieve anxiety and treat insomnia. This study compared the similarities and differences in the chromone components of two types of agarwood. It further investigated the absorption and brain distribution characteristics of these components in rats and their neuroprotective effects mediated through anti-neuroinflammatory pathways. Methods: This study confirmed, through ITS2 barcoding and chloroplast genome analysis, that both the ordinary and Qi-Nan agarwood are derived from Aquilaria sinensis. A comparative analysis of chromones in ethanol extracts derived from ordinary and Qi-Nan agarwood, as well as those capable of penetrating the blood-brain barrier in vivo, was conducted using UPLC-Q-TOF-MS. Subsequently, an in vitro neuroinflammatory model was established via lipopolysaccharide (LPS)-stimulated BV-2 cells to evaluate the anti-neuroinflammatory activity of differential chromones. Results: UPLC-Q-TOF-MS characterization revealed the chromone components in the two types of agarwood: A total of 81 chromone compounds were identified in the ethanol extracts of ordinary agarwood (OAE) (20 THPECs, 42 FTPECs, and 19 BI), while 41 were identified in the ethanol extracts of Qi-Nan agarwood (QNE) (11 THPECs and 30 FTPECs). Pharmacokinetic analysis in rats showed that 14 components from OAE (eight THPECs and six FTPECs) penetrated the rat serum, and 10 of these 14 components penetrated the blood–brain barrier (BBB). Twelve FTPECs from QNE penetrated the rat serum, all of which penetrated the BBB. The total peak area of the total ion current (TIC) was calculated for the samples, and the TIC of the serum was compared to that of the brain tissue from the same rat to roughly estimate the ratio. The results demonstrated that the capability of FTPECs to traverse the blood–brain barrier is substantially superior to that of THPECs. Correspondingly, only FTPECs were detected using DESI-MS imaging; no THPECs were detected in rat brain tissue, and DESI-MS imaging localized FTPECs to neuroanatomic regions (cerebral cortex, thalamus, and hippocampus). In vitro neuroinflammatory assays revealed the superior anti-inflammatory efficacy of QNE over OAE (IL-6/TNF-α suppression, p < 0.05), correlating with its FTPEC-rich composition. Conclusions: Structure–activity relationships identified FTPECs as potent inhibitors of pro-inflammatory cytokines, exhibiting enhanced BBB penetration (blood–brain relative abundance > 1). These findings establish FTPECs as prioritized candidates for CNS-targeted therapeutics, with QNE’s pharmacological superiority attributed to its FTPEC dominance and optimized BBB transit capacity.
- Open Access
- 25 November 2024
- Published by Wolters Kluwer Health in World Journal of Traditional Chinese Medicine
- Vol. 11 (1) , 112-124
Glycosides of Tripterygium wilfordii Hook. F Inhibits Bone Loss in Rheumatoid Arthritis by Downregulating Interleukin-8/C-X-C Motif Chemokine Receptor 2 Signaling Pathway
Objective: The objective of this study was to investigate the effect of glycosides of Tripterygium wilfordii Hook. F (GTW) on bone erosion in collagen-induced arthritis (CIA) rats and osteoclastogenesis. Materials and Methods: The effects of GTW on bone destruction were assessed through hematoxylin and eosin analyses and tartrate-resistant acid phosphatase (TRAP) staining. In vitro, TRAP staining, F-actin, and quantitative polymerase chain reaction assays were used to evaluate the inhibitory effects of GTW on osteoclast differentiation. In addition, Western blot, immunohistochemistry, and immunofluorescence staining techniques were employed to explore the mechanisms of GTW by determining the expression of interleukin-8 (IL-8), C-X-C motif chemokine receptor 2 (CXCR2), nuclear factor of activated T cells 1 (NFATc1), and p65. Results: GTW slowed the onset of arthritis and reduced arthritis scores. Our mechanistic studies demonstrated that GTW reduced the number of osteoclasts in rats with CIA and significantly suppressed receptor activator of nuclear factor kappa-B ligand-induced osteoclast differentiation, as evidenced by a decrease in TRAP-positive cells, alterations in F-actin rings, and modulation of osteoclast-specific gene expression. The inhibition of IL-8, CXCR2, NFATc1, and p65 activation by GTW was observed in both CIA rats and osteoclasts. Conversely, the introduction of IL-8 into the osteoclast culture system mitigated the effects of GTW on osteoclast differentiation. Conclusions: Our findings suggest that GTW suppressed osteoclastogenesis and bone loss by inhibiting the IL-8/CXCR2 signaling pathway. These results offer valuable insights into the potential therapeutic role of GTW in rheumatoid arthritis and lay the groundwork for future clinical applications.
- 25 November 2024
- Published by Wolters Kluwer Health in World Journal of Traditional Chinese Medicine
- Vol. 11 (1) , 112-124
Open AccessGlycosides of Tripterygium wilfordii Hook. F Inhibits Bone Loss in Rheumatoid Arthritis by Downregulating Interleukin-8/C-X-C Motif Chemokine Receptor 2 Signaling Pathway
Objective: The objective of this study was to investigate the effect of glycosides of Tripterygium wilfordii Hook. F (GTW) on bone erosion in collagen-induced arthritis (CIA) rats and osteoclastogenesis. Materials and Methods: The effects of GTW on bone destruction were assessed through hematoxylin and eosin analyses and tartrate-resistant acid phosphatase (TRAP) staining. In vitro, TRAP staining, F-actin, and quantitative polymerase chain reaction assays were used to evaluate the inhibitory effects of GTW on osteoclast differentiation. In addition, Western blot, immunohistochemistry, and immunofluorescence staining techniques were employed to explore the mechanisms of GTW by determining the expression of interleukin-8 (IL-8), C-X-C motif chemokine receptor 2 (CXCR2), nuclear factor of activated T cells 1 (NFATc1), and p65. Results: GTW slowed the onset of arthritis and reduced arthritis scores. Our mechanistic studies demonstrated that GTW reduced the number of osteoclasts in rats with CIA and significantly suppressed receptor activator of nuclear factor kappa-B ligand-induced osteoclast differentiation, as evidenced by a decrease in TRAP-positive cells, alterations in F-actin rings, and modulation of osteoclast-specific gene expression. The inhibition of IL-8, CXCR2, NFATc1, and p65 activation by GTW was observed in both CIA rats and osteoclasts. Conversely, the introduction of IL-8 into the osteoclast culture system mitigated the effects of GTW on osteoclast differentiation. Conclusions: Our findings suggest that GTW suppressed osteoclastogenesis and bone loss by inhibiting the IL-8/CXCR2 signaling pathway. These results offer valuable insights into the potential therapeutic role of GTW in rheumatoid arthritis and lay the groundwork for future clinical applications.
- 10 October 2024
- Published by Elsevier in Phytomedicine
- Vol. 135, 156147
Qingxin Jieyu Granule alleviates myocardial infarction through inhibiting neutrophil extracellular traps via activating ANXA1/FPR2 axis
- 10 October 2024
- Published by Elsevier in Phytomedicine
- Vol. 135, 156147
Qingxin Jieyu Granule alleviates myocardial infarction through inhibiting neutrophil extracellular traps via activating ANXA1/FPR2 axis